PL3358355T3 - Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób - Google Patents
Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych choróbInfo
- Publication number
- PL3358355T3 PL3358355T3 PL17461508.8T PL17461508T PL3358355T3 PL 3358355 T3 PL3358355 T3 PL 3358355T3 PL 17461508 T PL17461508 T PL 17461508T PL 3358355 T3 PL3358355 T3 PL 3358355T3
- Authority
- PL
- Poland
- Prior art keywords
- diseases
- prdx
- adpkd
- igan
- ckd
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 title 1
- 208000010159 IgA glomerulonephritis Diseases 0.000 title 1
- 206010021263 IgA nephropathy Diseases 0.000 title 1
- 208000005777 Lupus Nephritis Diseases 0.000 title 1
- 102000007456 Peroxiredoxin Human genes 0.000 title 1
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000020832 chronic kidney disease Diseases 0.000 title 1
- 230000004069 differentiation Effects 0.000 title 1
- 108030002458 peroxiredoxin Proteins 0.000 title 1
- 210000002966 serum Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17461508.8A EP3358355B1 (en) | 2017-02-04 | 2017-02-04 | Use of serum 2-cysteine peroxiredoxins (2-cys-prdx) as biomarkers of chronic kidney diseases (ckd) such as lupus nephritis (ln), iga nephropathy (igan) and autosomal-dominant polycystic kidney disease (adpkd) useful for diagnosing, these diseases and method of differentiation of these diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3358355T3 true PL3358355T3 (pl) | 2024-04-08 |
Family
ID=57984871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17461508.8T PL3358355T3 (pl) | 2017-02-04 | 2017-02-04 | Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200064344A1 (pl) |
| EP (1) | EP3358355B1 (pl) |
| AU (1) | AU2018215249A1 (pl) |
| CA (1) | CA3052545A1 (pl) |
| IL (1) | IL268477A (pl) |
| PL (1) | PL3358355T3 (pl) |
| WO (1) | WO2018141975A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102403211B1 (ko) * | 2020-08-21 | 2022-05-27 | 중앙대학교 산학협력단 | 퍼옥시레독신 4를 이용한 포유동물의 산자수 예측용 조성물 |
| CN115598350A (zh) * | 2022-10-14 | 2023-01-13 | 中南大学湘雅医院（Cn） | 检测Prdx1蛋白的试剂在制备急性器官损伤或脓毒症的早期诊断/预后产品中的应用 |
| CN117491636B (zh) * | 2023-11-21 | 2026-02-06 | 郑州大学 | 一种用于肺癌诊断的生物标志物及其应用 |
| CN118962136B (zh) * | 2024-10-17 | 2024-12-13 | 中南大学湘雅二医院 | Prdx2作为生物标志物在急性肾损伤辅助诊断和预后预测中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100986225B1 (ko) | 2001-02-16 | 2010-10-07 | 아스비오파마 가부시키가이샤 | Ａｏｐ－１ 유전자 또는 ａｏｐ－１의 발현 감소를수반하는 질환의 치료 방법 및 상기 질환의 치료약 |
| WO2005116082A1 (en) | 2004-05-27 | 2005-12-08 | Industry-Academic Cooperation Foundation Gyeong Sang National University | 2-cysteine peroxiredoxin complex exhibiting function acting as molecular chaperone and uses thereof |
| US20090269772A1 (en) | 2008-04-29 | 2009-10-29 | Andrea Califano | Systems and methods for identifying combinations of compounds of therapeutic interest |
| KR100928403B1 (ko) | 2008-10-01 | 2009-11-26 | 경북대학교 산학협력단 | 티지비엠 신증의 진단용 조성물 및 키트 |
| ES2552773T3 (es) | 2009-02-27 | 2015-12-02 | Atyr Pharma, Inc. | Motivos estructurales de polipéptidos asociados con la actividad de señalización celular |
| WO2011081229A1 (ko) | 2009-12-29 | 2011-07-07 | 이화여자대학교 산학협력단 | 혈관신생 억제용 약제학적 조성물 |
| US20130040833A1 (en) | 2010-05-12 | 2013-02-14 | The General Hospital Corporation | Use of microvesicles in analyzing nucleic acid profiles |
| WO2012033999A2 (en) | 2010-09-10 | 2012-03-15 | The Ohio State University | Biomarkers for predicting kidney and glomerular pathologies |
| JP6271250B2 (ja) * | 2010-09-21 | 2018-01-31 | プロテオミクス インターナショナル プロプライエタリー リミテッドＰｒｏｔｅｏｍｉｃｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ Ｌｔｄ | 糖尿病前症、糖尿病、および糖尿病関連症状に関連するバイオマーカー |
| US20140038203A1 (en) * | 2012-07-09 | 2014-02-06 | Musc Foundation For Research Development | Methods for detecting or predicting kidney disease |
| US20140221325A1 (en) * | 2013-02-01 | 2014-08-07 | Meso Scale Technologies, Llc | Glomerulonephritis biomarkers |
| EP3278109A4 (en) | 2015-03-30 | 2018-08-15 | Hycor Biomedical, Inc. | Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases |
-
2017
- 2017-02-04 PL PL17461508.8T patent/PL3358355T3/pl unknown
- 2017-02-04 EP EP17461508.8A patent/EP3358355B1/en active Active
-
2018
- 2018-02-05 CA CA3052545A patent/CA3052545A1/en not_active Abandoned
- 2018-02-05 WO PCT/EP2018/052837 patent/WO2018141975A1/en not_active Ceased
- 2018-02-05 US US16/483,251 patent/US20200064344A1/en not_active Abandoned
- 2018-02-05 AU AU2018215249A patent/AU2018215249A1/en not_active Abandoned
-
2019
- 2019-08-04 IL IL268477A patent/IL268477A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018141975A1 (en) | 2018-08-09 |
| US20200064344A1 (en) | 2020-02-27 |
| CA3052545A1 (en) | 2018-08-09 |
| EP3358355A1 (en) | 2018-08-08 |
| AU2018215249A1 (en) | 2019-08-22 |
| EP3358355B1 (en) | 2023-10-11 |
| IL268477A (en) | 2019-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3734395A4 (en) | METHOD OF SWITCHING THE OPERATING MODE OF A CARDAN SUSPENSION AND CONTROL AND IMAGE STABILITY ENHANCEMENT DEVICE | |
| EP3776445A4 (en) | PROCESSING DATA TO PREDICT A PIPELINE FAILURE | |
| PL3707466T4 (pl) | Metoda lokalizacji i nawigacji oparta na komputerowej wizji oraz system do jej wykonywania | |
| DK3688155T5 (da) | Universel platform til fremstilling af en inhibitorisk kimær antigenreceptor (icar) | |
| WO2015176066A3 (en) | Lpa-associated protein and rna expression | |
| EP3161481A4 (en) | System for assessing global wellness | |
| EP3221835A4 (en) | Model-based prediction of an optimal convenience metric for authorizing transactions | |
| EP3222728A4 (en) | Method for regulating gene expression using cas9 protein expressed from two vectors | |
| EP3279819A4 (en) | Method, system and computer device for capacity prediction based on kalman filter | |
| WO2015073884A3 (en) | Glycoengineered antibody compositions | |
| EP3376229A4 (en) | BIOMARKERS FOR THE DIAGNOSIS OF DEPRESSIONS AND THE USE OF THE BIOMARKER | |
| EP3538893A4 (en) | PROCESSES FOR IDENTIFYING CANDIDATE BIOMARKERS | |
| EP3190416A4 (en) | Biomarker for predicting sensitivity to protein kinase inhibitor and use thereof | |
| EP3191629A4 (en) | Peptide microarrays and novel biomarkers for celiac disease | |
| EP3894581A4 (en) | NUCLEIC ACID BIOMARKERS OF PLACENTAL DYSFUNCTION | |
| EP3200841A4 (en) | Cardiosphere-derived cells (cdcs) as therapeutic agents for pulmonary hypertension | |
| EP3273295A4 (en) | Glasses for aligning the cervical vertebrae | |
| EP3695224A4 (en) | Prognosis and progression biomarkers for chronic kidney disease | |
| IL268477A (en) | Use of serum 2-cysteine peroxyredoxins (2-cis-Praders) as biomarkers of chronic kidney diseases | |
| PL3235666T3 (pl) | Miech na przejściu pomiędzy dwoma pojazdami połączonymi przegubowo | |
| HK1244534A1 (zh) | 重组疏螺旋体蛋白及其使用方法 | |
| EP3400441A4 (en) | SIGNATURES OF BIOMARKERS FOR THE DIFFERENTIATION OF LYME DISEASE AND METHODS OF USE THEREOF | |
| EP3112867A4 (en) | Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit | |
| SI3337817T1 (sl) | Postopek za redukcijo beljakovin gostiteljske celice pri afinitetni kromatografiji | |
| EP3323828A4 (en) | ANTIBODIES FOR DETERMINING THE SEX OF SPERMA AND USE THEREOF |